CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
78 hedge funds and large institutions have $220M invested in Crescent Biopharma, Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 27 reducing their positions, and 14 closing their positions.
Holders
78
Holders Change
+3
Holders Change %
+4%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
21
Reduced
27
Closed
14
Calls
$74K
Puts
$39K
Net Calls
+$35K
Net Calls Change
-$26K
Top Buyers
Top Sellers
1 |
RG
1
Redmile Group
San Francisco,
California
|
$7.11M |
2 |
2
Millennium Management
New York
|
$414K |
3 |
3
Wellington Management Group
Boston,
Massachusetts
|
$19.6M |
4 |
4
Citadel Advisors
Miami,
Florida
|
$1.43M |
5 |
5
BlackRock
New York
|
$15M |